Literature DB >> 30049420

Frizzleds as GPCRs - More Conventional Than We Thought!

Gunnar Schulte1, Shane C Wright2.   

Abstract

For more than 30 years, WNT/β-catenin and planar cell polarity signaling has formed the basis for what we understand to be the primary output of the interaction between WNTs and their cognate receptors known as Frizzleds (FZDs). In the shadow of these pathways, evidence for the involvement of heterotrimeric G proteins in WNT signaling has grown substantially over the years - redefining the complexity of the WNT signaling network. Moreover, the distinct characteristics of FZD paralogs are becoming better understood, and we can now apply concepts valid for classical GPCRs to grasp FZDs as molecular machines at the interface of ligand binding and intracellular effects. This review discusses recent developments in the field of WNT/FZD signaling in the context of GPCR pharmacology, and identifies remaining mysteries with an emphasis on structural and kinetic components that support this dogma shift.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dishevelled; Frizzled; GPCR; WNT; heterotrimeric G proteins; ternary complex model

Mesh:

Substances:

Year:  2018        PMID: 30049420     DOI: 10.1016/j.tips.2018.07.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  20 in total

1.  WNT-3A-induced β-catenin signaling does not require signaling through heterotrimeric G proteins.

Authors:  Carl-Fredrik Bowin; Asuka Inoue; Gunnar Schulte
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

Review 2.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

3.  Wnt3 distribution in the zebrafish brain is determined by expression, diffusion and multiple molecular interactions.

Authors:  Sapthaswaran Veerapathiran; Cathleen Teh; Shiwen Zhu; Indira Kartigayen; Vladimir Korzh; Paul T Matsudaira; Thorsten Wohland
Journal:  Elife       Date:  2020-11-25       Impact factor: 8.140

4.  Frizzled7 Activates β-Catenin-Dependent and β-Catenin-Independent Wnt Signalling Pathways During Developmental Morphogenesis: Implications for Therapeutic Targeting in Colorectal Cancer.

Authors:  Bang Manh Tran; Dustin James Flanagan; Toby James Phesse; Elizabeth Vincan
Journal:  Handb Exp Pharmacol       Date:  2021

5.  Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.

Authors:  Ali Vural; Stephen M Lanier
Journal:  J Cell Sci       Date:  2020-09-04       Impact factor: 5.285

Review 6.  G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.

Authors:  Nadia Arang; J Silvio Gutkind
Journal:  FEBS Lett       Date:  2020-12       Impact factor: 4.124

7.  eGFP-tagged Wnt-3a enables functional analysis of Wnt trafficking and signaling and kinetic assessment of Wnt binding to full-length Frizzled.

Authors:  Janine Wesslowski; Pawel Kozielewicz; Xianxian Wang; Haijun Cui; Hannes Schihada; Dominique Kranz; Pradhipa Karuna M; Pavel Levkin; Julia Christina Gross; Michael Boutros; Gunnar Schulte; Gary Davidson
Journal:  J Biol Chem       Date:  2020-05-07       Impact factor: 5.157

8.  Residue 6.43 defines receptor function in class F GPCRs.

Authors:  Hannes Schihada; Pawel Kozielewicz; Ainoleena Turku; Carl-Fredrik Bowin; Gunnar Schulte
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

9.  Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.

Authors:  Njainday Pulo Jobe; Lisa Åsberg; Tommy Andersson
Journal:  Mol Oncol       Date:  2021-05-15       Impact factor: 6.603

10.  Quantitative Profiling of WNT-3A Binding to All Human Frizzled Paralogues in HEK293 Cells by NanoBiT/BRET Assessments.

Authors:  Paweł Kozielewicz; Rawan Shekhani; Stefanie Moser; Carl-Fredrik Bowin; Janine Wesslowski; Gary Davidson; Gunnar Schulte
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.